Skip to main content Skip to navigation
Anti-Mouse CD117 Magnetic Particles - DM
Anti-Mouse CD117 Magnetic Particles - DM

Positive selection of mouse CD117+ progenitor cells from mouse bone marrow. Mouse bone marrow cells were labeled with BD IMag™ anti-mouse CD117 Particles - DM (Cat. No.  558620) as described in the protocol. After labeling, the cells were separated using the BD IMag™ Cell Separation Magnet (Cat. No. 552311), and the negative (CD117-) and positive (CD117+) fractions were collected.  Please refer to the Separation Flow Chart to identify the separated cell populations represented in this figure. For flow cytometric analysis, fresh bone marrow cells (left panel), the negative fraction (middle panel), and the positive fraction (right panel) were stained with PE Mouse Anti-Mouse CD117 (Cat. No. 553869) and APC Rat Anti-Mouse CD45 (Cat. no. 559864). The percent CD117+/CD45+ cells in each sample is given.

Positive selection of mouse CD117+ progenitor cells from mouse bone marrow. Mouse bone marrow cells were labeled with BD IMag™ anti-mouse CD117 Particles - DM (Cat. No.  558620) as described in the protocol. After labeling, the cells were separated using the BD IMag™ Cell Separation Magnet (Cat. No. 552311), and the negative (CD117-) and positive (CD117+) fractions were collected.  Please refer to the Separation Flow Chart to identify the separated cell populations represented in this figure. For flow cytometric analysis, fresh bone marrow cells (left panel), the negative fraction (middle panel), and the positive fraction (right panel) were stained with PE Mouse Anti-Mouse CD117 (Cat. No. 553869) and APC Rat Anti-Mouse CD45 (Cat. no. 559864). The percent CD117+/CD45+ cells in each sample is given.

Product Details
Down Arrow Up Arrow


BD IMag™
c-KIT; W; SCFR; Stem Cell Factor Receptor; Sl; Steel Factor Receptor; Ssm
Mouse (QC Testing)
Rat WI, also known as Wistar (outbred) IgG2b, κ
Mouse Bone Marrow Mast Cells
Cell separation (Routinely Tested)
16590
AB_1645239
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
RUO


Preparation And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. Antibody or streptavidin was conjugated to the magnetic particles under optimum conditions, and unconjugated antibody/streptavidin was removed.

Recommended Assay Procedures

A single-cell suspension from the lymphoid tissue of interest is labeled with BD IMag™ anti-mouse CD117 Particles - DM according to the Magnetic Labeling Protocol.  This labeled cell suspension is then placed within the magnetic field of the BD IMag™ Cell Separation Magnet (Cat. no. 552311).  Labeled cells migrate toward the magnet (positive fraction), leaving the unlabeled cells in suspension so they can be drawn off (negative fraction).  The tube is then removed from the magnetic field for resuspension of the positive fraction.  The separation is repeated twice to increase the purity of the positive fraction.  The magnetic separation steps are diagrammed in the Separation Flow Chart.  After the positive fraction is washed, the small size of the magnetic particles allows the positive fraction to be further evaluated in downstream applications such as flow cytometry.

MAGNETIC LABELING PROTOCOL

1.  Prepare a single-cell suspension from the lymphoid tissue of interest according to standard laboratory procedures. Remove clumps of cells and/or debris by passing the suspension through a 70-mm nylon cell strainer.

2.  Dilute BD IMag™ Buffer (10X) (Cat. no. 552362) 1:10 with sterile distilled water or prepare 1X BD IMag™ buffer by supplementing Phosphate Buffered Saline with 0.5% BSA, 2 mM EDTA, and 0.09% sodium azide.  Store at 4˚C.

3.  Wash cells with an excess volume of 1X BD IMag™ buffer, and carefully aspirate all the supernatant.

4. Vortex the BD IMag™ anti-mouse CD117 Magnetic Particles - DM thoroughly, and add 50 μl of particles for every 10 million total cells.

5. MIX THOROUGHLY.  Refrigerate at 6°C to 12°C for 30 minutes.

6. Bring the BD IMag™-particle labeling volume up to 10 to 80 million cells/ml with 1X BD IMag™ buffer, and immediately place the tube on the Cell Separation Magnet.  Incubate at room temperature for 8-10 minutes.

7.  With the tube on the Cell Separation Magnet, carefully pipette off the supernatant.  This supernatant contains the negative fraction.

8. Remove the tube from the Cell Separation Magnet, and add 1 ml of 1X BD IMag™ buffer.  Gently resuspend cells by pipetting up and down, and return the tube to the Cell Separation Magnet for another 2 - 4 minutes.

9.  With the tube on the Cell Separation Magnet, carefully pipette off the supernatant and discard.

10.  Repeat Steps 8 and 9.

11.  After the final wash step, resuspend the positive fraction in an appropriate buffer or media, and proceed with desired downstream application(s).

NOTE:  The concentration of BD IMag™ anti-mouse CD117 Particles - DM suggested in the protocol has been optimized for the purification of CD117-positive cells from mouse bone marrow.  When labeling target cell populations present at lower frequencies, fewer BD IMag™ particles can be used.  Conversely, when labeling target cell populations that are present at higher frequencies, more particles should be used.  To determine the optimal concentration of the BD IMag™ anti-mouse CD117 Particles - DM for a particular application, a titration in two-fold increments is recommended.

NOTE:  Avoid nonspecific labeling by working quickly and keeping incubation times as recommended.

Product Notices

  1. BD IMag™ particles are prepared from carboxy-functionalized magnetic particles which are manufactured by Skold Technology and are licensed under US patent number 7,169,618.
  2. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  3. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
  4. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
558620 Rev. 2
Antibody Details
Down Arrow Up Arrow
2B8

BD IMag™ anti-mouse CD117 Magnetic Particles - DM are magnetic nanoparticles that have monoclonal antibody conjugated to their surfaces.  These particles are optimized for the positive selection or depletion of CD117-bearing cells using the BD IMag™ Cell Separation Magnet.  The 2B8 antibody reacts with CD117 (c-Kit), a transmembrane tyrosine-kinase receptor which is encoded by the Kit gene (formerly dominant white spotting, W). The c-Kit ligand (also known as steel factor, stem cell factor, and mast cell growth factor) encoded by the Kit1 gene (formerly steel, SI), is a co-mitogen for hematopoietic stem cells, myeloerythroid progenitors and a mast-cell differentiation factor. The KitW and Kit1SI mutant alleles have similar pleiotropic effects on the development of melanocytes, germ cells, and the hematopoietic system. In the adult bone marrow, CD117 is expressed on hematopoietic progenitor cells, including CD90 (Thy-1) low, TER-119-, CD45R/B220-, CD11b (Mac-1)-, Ly-6G (Gr-1)-, CD4-, CD8-, and Sca-1 (Ly-6A/E)+ multipotent hemotopoietic stem cells, progenitors committed to myeliod and/or erythroid lineages, and precursors of B and T lymphocytes. This widespread expression of CD117 in hematopoietic precursors is consistent with the participation of c-Kit and its ligand in the regulation of several hematopoietic lineages. Intrathymic expression of c-Kit and c-Kit ligand suggest that CD117 is also involved in the regulation of some events during the development of T lymphocytes. CD117 is also expressed by mast cells and by dendritic cells found in the periarteriolar lymphocytoc sheaths (T-cell areas) of splenic white pulp. The mAb 2B8 reportedly does not block the action of c-Kit.

558620 Rev. 2
Format Details
Down Arrow Up Arrow
BD IMag DM
BD IMag DM
558620 Rev.2
Citations & References
Down Arrow Up Arrow

Development References (15)

  1. Anderson DM, Lyman SD, Baird A, et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell. 1990; 63(1):235-243. (Biology). View Reference
  2. Austen KF, Boyce JA. Mast cell lineage development and phenotypic regulation. Leuk Res. 2001; 25(7):511-518. (Biology). View Reference
  3. Domen J, Weissman IL. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med. 2000; 192(12):1707-1718. (Biology). View Reference
  4. Godfrey DI, Zlotnik A. Control points in early T-cell development. Immunol Today. 1993; 14(11):547-553. (Biology). View Reference
  5. Huang E, Nocka K, Beier DR, et al. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell. 1990; 63(1):225-233. (Biology). View Reference
  6. Ikuta K, Weissman IL. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A. 1992; 89(4):1502-1506. (Biology). View Reference
  7. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997; 91(5):661-672. (Biology). View Reference
  8. Lian Z, Toki J, Yu C, et al. Intrathymically injected hemopoietic stem cells can differentiate into all lineage cells in the thymus: differences between c-kit+ cells and c-kit < low cells. Stem Cells. 1997; 15(6):430-436. (Biology). View Reference
  9. Mirmonsef P, Shelburne CP, Fitzhugh Yeatman C 2nd, Chong HJ, Ryan JJ. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase. J Immunol. 1999; 163(5):2530-2539. (Biology). View Reference
  10. Ogawa M, Matsuzaki Y, Nishikawa S, et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med. 1991; 174(1):63-71. (Biology). View Reference
  11. Ogawa M, Nishikawa S, Yoshinaga K, et al. Expression and function of c-Kit in fetal hemopoietic progenitor cells: transition from the early c-Kit-independent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo. Development. 1993; 117(3):1089-1098. (Biology). View Reference
  12. Pulendran B, Lingappa J, Kennedy MK, et al. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol. 1997; 159(5):2222-2231. (Biology). View Reference
  13. Rodewald HR, Kretzschmar K, Swat W, Takeda S. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity. 1995; 3(3):313-319. (Biology). View Reference
  14. Valent P. The riddle of the mast cell: kit(CD117)-ligand as the missing link?. Immunol Today. 1994; 15(3):111-114. (Biology). View Reference
  15. Zsebo KM, Wypych J, McNiece IK, et al. Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium. Cell. 1990; 63(1):195-201. (Biology). View Reference
View All (15) View Less
558620 Rev. 2

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.

Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.